Section II
1 – 10 of 9395
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
DAPAgliflozin for renal protection in heart transplant recipients. Rationale and design of the randomized controlled DAPARHT trial
- Contribution to journal › Article
-
Mark
Long-acting nitrate use before and after revascularization to evaluate angina in chronic coronary syndrome : a case-crossover study from SCAAR
- Contribution to journal › Article
- 2025
-
Mark
Major immediate insertion-related complications after central venous catheterisation and associations with mortality, length of hospital stay, and costs : A prospective observational study
- Contribution to journal › Article
-
Mark
Comparison of CSF biomarkers in multiple sclerosis patients treated with natalizumab and rituximab
- Contribution to journal › Article
-
Mark
Intermediate Monocytes and High Levels of Chemokine CCL3 Are Associated With Increased Risk of Atrial Fibrillation in the General Population
- Contribution to journal › Article
-
Mark
Enhanced glomerular thrombosis in pronated animals with ARDS
- Contribution to journal › Article
-
Mark
Vocational awe is (not) enough : Learnings from early adopters of serious illness communication
- Contribution to journal › Article
-
Mark
Five years of the Early-Career Geriatricians Initiative (ECGI) : reflecting on the past, shaping the present, and envisioning the future
- Contribution to journal › Article
-
Mark
Integrating environmental outcomes in randomised clinical trials : a call to action
- Contribution to journal › Debate/Note/Editorial
-
Mark
What Do We Owe Our Genetic Relatives?
- Contribution to journal › Article
